Last reviewed · How we verify

NCT03138668

Cutaneous Anesthesia of the Lateral Femoral Cutaneous Nerve

Completed Phase 2 Last updated 14 June 2017
What this trial tests

Phase 2 trial testing Ropivacaine Injection in Nerve Block in 20 participants. Completed in 9 June 2017.

Timeline
19 May 2017
Primary endpoint
9 June 2017
9 June 2017

Quick facts

Lead sponsorZealand University Hospital
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment20
Start date19 May 2017
Primary completion9 June 2017
Estimated completion9 June 2017
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Zealand University Hospital

Who can join

18 and older, any sex, with Nerve Block or Anesthesia, Local. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate and describe the anatomical differences in distribution of the blocked area following a perineural LFCN (Lateral Femoris Cutaneous Nerve) block with either 8 ml or 16 ml of Ropivacaine, in relation to incision lines used in THA (Total Hip Arthroplasty). Furthermore, we examine any loss of motor function in Musculus Quadriceps due to posible involvement of the Femoral Nerve. This trial will be conducted in healthy volunteers, as a blinded, randomized, paired trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lateral femoral cutaneous nerve block with different volumes of Ropivacaine: a randomized trial in healthy volunteers.
    Vilhelmsen F, Nersesjan M, Andersen JH, Danker JK, et al · · 2019 · cited 13× · PMID 31455249 · DOI 10.1186/s12871-019-0833-4

Verify or expand the search:

Other trials of Ropivacaine Injection

Trials testing the same drug.

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

Other Zealand University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03138668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing